Patients With Kidney Disease a Blind Spot in Most CV TrialsPatients With Kidney Disease a Blind Spot in Most CV Trials

They're excluded from most cardiovascular procedure, device, and drug trials, a study finds; yet it's "nearly inevitable" specialists will see patients with both CV and kidney disease in daily practice. Heartwire from Medscape
Source: theHeart.org - Category: Cardiology Tags: Cardiology News Source Type: news